Tag: BioTech, PE, VC & Alternatives

20VC: Accel’s Sonali De Rycker on Building a Generational Defining Venture Firm; Hiring, Culture, Incentives | Investing; Biggest Mistakes, Biggest Lessons from Prior Crashes,...

Venture CapitalJune 27, 2022

Posted on 27th June 2022 by hstebbings1Sonali De Rycker is a Partner @ Accel, one of the leading firms of the last 3 decades...

20VC: From Kitchen Table to $134M Fund II; Raising Your First Time Fund: Lessons from 400 LP Meetings, How To Find New LPs, What...

Venture CapitalJune 24, 2022

Posted on 24th June 2022 by hstebbings1Henri Pierre-Jacques is Managing Partner of Harlem Capital, on a mission to change the face of entrepreneurship by...

20 Sales: Why Founders Should Not Be The One To Create The Sales Playbook, How To Structure Each Interview in the Hiring Process For...

Venture CapitalJune 22, 2022

Posted on 22nd June 2022 by hstebbings1Zhenya Loginov is the CRO @ Miro, the leading visual collaboration platform that helps bring teams together and...

20VC: Gary Vaynerchuk on The Most Painful Lessons Learned but Why it was Good to Learn Them, Why You Have to Change the Timeframe...

Venture CapitalJune 20, 2022

Posted on 20th June 2022 by hstebbings1Gary Vaynerchuk is a serial entrepreneur and serves as the Chairman of VaynerX, the CEO of VaynerMedia and the Creator &...

1...3 45Page 5 of 5

Latest Intelligence

20VC: Lessons from Alfred Lin and Ron Conway | Why the World Does Not Want Your Startup To Exist and How the Best Founders...

Venture Capital September 30, 2022

20Growth: Hubspot CMO Kipp Bodnar on Why the Best Marketers Think Like VCs | Why the Best Companies Do Not Start with Product Marketing...

Venture Capital September 28, 2022

20VC: Clubhouse Founder Paul Davison on What Went Right and What Went Wrong | What Does Clubhouse Do Now To Regain Mindshare? | Why...

Venture Capital September 26, 2022

20VC: Why Greed is the #1 Enemy of Venture Returns, Why Not Enough VCs Play to Win and Lessons from Scaling to $100M and...

Venture Capital September 23, 2022

20 Product: The No 1 Metric You Need To Look at When Building Product | Why the Best in Product Have No Domain Experience...

Venture Capital September 21, 2022

20VC: From Struggling to Raise Funding to IPOing at Close to $9BN Just Five Years Later; The $8BN Company You Might Not Know |...

Venture Capital September 16, 2022

20 Sales: Scaling Retool to $50M in ARR; The Top Sales Tips and Lessons, How Sales Leaders Should Change Goals and Quotas in Harder...

Venture Capital September 14, 2022

20 Product: The No 1 Metric You Need To Look at When Building Product | Why the Best in Product Have No Domain Experience...

Venture Capital September 21, 2022

20VC: From Struggling to Raise Funding to IPOing at Close to $9BN Just Five Years Later; The $8BN Company You Might Not Know |...

Venture Capital September 16, 2022

20 Sales: Scaling Retool to $50M in ARR; The Top Sales Tips and Lessons, How Sales Leaders Should Change Goals and Quotas in Harder...

Venture Capital September 14, 2022

Plato Data Intelligence.
Vertical Search & Ai.

Tag: BioTech, PE, VC & Alternatives

Latest Intelligence

20VC: Lessons from Alfred Lin and Ron Conway | Why the World Does Not Want Your Startup To Exist and How the Best Founders...

20Growth: Hubspot CMO Kipp Bodnar on Why the Best Marketers Think Like VCs | Why the Best Companies Do Not Start with Product Marketing...

20VC: Clubhouse Founder Paul Davison on What Went Right and What Went Wrong | What Does Clubhouse Do Now To Regain Mindshare? | Why...

20VC: Why Greed is the #1 Enemy of Venture Returns, Why Not Enough VCs Play to Win and Lessons from Scaling to $100M and...

20 Product: The No 1 Metric You Need To Look at When Building Product | Why the Best in Product Have No Domain Experience...

20VC: From Struggling to Raise Funding to IPOing at Close to $9BN Just Five Years Later; The $8BN Company You Might Not Know |...

20 Sales: Scaling Retool to $50M in ARR; The Top Sales Tips and Lessons, How Sales Leaders Should Change Goals and Quotas in Harder...

20 Product: The No 1 Metric You Need To Look at When Building Product | Why the Best in Product Have No Domain Experience...

20VC: From Struggling to Raise Funding to IPOing at Close to $9BN Just Five Years Later; The $8BN Company You Might Not Know |...

20 Sales: Scaling Retool to $50M in ARR; The Top Sales Tips and Lessons, How Sales Leaders Should Change Goals and Quotas in Harder...

Chat with us

Plato Data Intelligence.Vertical Search & Ai.

Tag: BioTech, PE, VC &amp; Alternatives

Latest Intelligence

Chat with us

Plato Data Intelligence.
Vertical Search & Ai.

Tag: BioTech, PE, VC & Alternatives